Quanterix Corporation (QTRX) - News Archive

Unlocking New Frontiers in Precision Medicine: Quanterix Accelerator Laboratory Secures Prestigious New York State Permit In a groundbreaking development poised to revolutionize the field of biomarker research, Quanteri...

Quanterix Elevates Biomarker Detection with Groundbreaking DBS Kit Amid Regulatory Challenges In an era where precision in biomedical research is paramount, Quanterix Corporation (NASDAQ: QTRX) is making significant str...

Quanterix Corporation Reports Strong Financial Growth Amid Industry Challenges: A Q4 2024 Analysis In a notable demonstration of resilience and strategic execution, Quanterix Corporation (NASDAQ: QTRX), a leader in ultr...

Quanterix Faces Nasdaq Compliance Challenge Amidst Market Struggles In a rather somber turn of events for Quanterix Corporation, the biotechnology firm based in Billerica, Massachusetts, has been formally notified by Th...

Quanterix Corporation, a prominent player in the diagnostics industry, finds itself navigating regulatory hurdles after receiving a compliance notice from Nasdaq. On November 21, 2024, the company was informed that it h...

Quanterix Commercializes p-Tau 217 Test Kit Amid Competitive Market Landscape Quanterix Corporation (NASDAQ: QTRX), a leader in ultrasensitive biomarker detection technology, has made significant strides in advancing di...

In a significant stride for Alzheimer’s disease (AD) diagnostics, Quanterix Corporation (NASDAQ: QTRX) announced the commercial launch of its Simoa p-Tau 217 Planar Kit. This cutting-edge test kit, benefiting from the c...

In a significant breakthrough for Alzheimer’s disease (AD) detection and diagnosis, Quanterix Corporation (NASDAQ: QTRX) has unveiled promising data at the recent Alzheimer’s Association International Conference (AAIC)...

Quanterix Outlines Partner Path to Accelerate Global Alzheimer s Disease Testing InfrastructureQuanterix Corporation, a prominent provider of ultra-sensitive research products and high-definition diagnostics, recently u...

Quanterix Corporation, a leading provider of ultra-sensitive research products and high-definition diagnostics, has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Simoa...

Quanterix Corporation, a prominent provider of ultra-sensitive research products and high-definition diagnostics, has recently announced its first collaborations with five major health networks. The aim of these collabo...